Tfg Asset Management Gp LTD Axsome Therapeutics, Inc. Transaction History
Tfg Asset Management Gp LTD
- $396 Million
- Q2 2025
A detailed history of Tfg Asset Management Gp LTD transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Tfg Asset Management Gp LTD holds 41,531 shares of AXSM stock, worth $5.47 Million. This represents 1.1% of its overall portfolio holdings.
Number of Shares
41,531
Previous 33,806
22.85%
Holding current value
$5.47 Million
Previous $3.94 Million
9.97%
% of portfolio
1.1%
Previous 1.14%
Shares
3 transactions
Others Institutions Holding AXSM
# of Institutions
409Shares Held
37.4MCall Options Held
507KPut Options Held
541K-
Vanguard Group Inc Valley Forge, PA3.95MShares$519 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$434 Million0.01% of portfolio
-
Bvf Inc San Francisco, CA1.69MShares$222 Million6.93% of portfolio
-
Rtw Investments, LP New York, NY1.52MShares$200 Million2.43% of portfolio
-
Macquarie Group LTD Australia, C31.14MShares$150 Million0.15% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $5.64B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...